These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 17637261)

  • 1. [Combination therapy of thymosin alpha1 and high dose dexamethasone in patients with chronic idiopathic thrombocytopenic purpura].
    Wang L; Guo CS; Hou M; Li LZ; Zhang CQ; Chen F; Qin P; Peng J; He WD; Chu XX
    Zhonghua Nei Ke Za Zhi; 2007 Apr; 46(4):274-6. PubMed ID: 17637261
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Correction of Th1-dominant cytokine profiles by high-dose dexamethasone in patients with chronic idiopathic thrombocytopenic purpura.
    Guo C; Chu X; Shi Y; He W; Li L; Wang L; Wang Y; Peng J; Hou M
    J Clin Immunol; 2007 Nov; 27(6):557-62. PubMed ID: 17619126
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Short term high-dose dexamethasone therapy in previously untreated idiopathic thrombocytopenic purpura].
    Li YF; Liu DS; Ding BH; Zhu JB; Chen BA
    Zhonghua Nei Ke Za Zhi; 2009 Sep; 48(9):734-6. PubMed ID: 20079208
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dexamethasone inhibits immunoreactivity of dendritic cells in patients with chronic idiopathic thrombocytopenic purpura.
    Chu XX; Huang BH; Zhang XL; Chen LM; Wang Y; Yu WJ; Wang XL; Qin YP
    Blood Coagul Fibrinolysis; 2010 Sep; 21(6):564-7. PubMed ID: 20581660
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Profiles of different subsets of CD(4)(+) T cells in chronic idiopathic thrombocytopenic purpura].
    Chang DY; Ouyang J; Zhou RF; Xu JY; Chen B; Yang YG; Zhang QG; Shao XY; Guan CY; Xu Y
    Zhonghua Nei Ke Za Zhi; 2010 Mar; 49(3):213-6. PubMed ID: 20450652
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Short-course high-dose dexamethasone therapy for chronic idiopathic thrombocytopenic purpura in children.
    Yadav D; Chandra J; Sharma S; Singh V
    J Trop Pediatr; 2010 Dec; 56(6):446-7. PubMed ID: 20388659
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The efficacy and safety of 2 cycles' high-dose dexamethasone treatment adult primary immune thrombocytopenia].
    Cui ZG; Wei Y; Hou M; Zhao HG; Wang HY
    Zhonghua Nei Ke Za Zhi; 2011 May; 50(5):401-3. PubMed ID: 21624223
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of high-dose dexamethasone in prednisone-resistant autoimmune thrombocytopenic purpura (ITP).
    Dubbeld P; van der Heul C; Hillen HF
    Neth J Med; 1991 Aug; 39(1-2):6-10. PubMed ID: 1961352
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High-dose dexamethasone as a first- and second-line treatment of idiopathic thrombocytopenic purpura in adults.
    Borst F; Keuning JJ; van Hulsteijn H; Sinnige H; Vreugdenhil G
    Ann Hematol; 2004 Dec; 83(12):764-8. PubMed ID: 15309522
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High response rate to low-dose rituximab plus high-dose dexamethasone as frontline therapy in adult patients with primary immune thrombocytopenia.
    Gómez-Almaguer D; Tarín-Arzaga L; Moreno-Jaime B; Jaime-Pérez JC; Ceballos-López AA; Ruiz-Argüelles GJ; Ruiz-Delgado GJ; Cantú-Rodríguez OG; Gutiérrez-Aguirre CH; Sánchez-Cárdenas M
    Eur J Haematol; 2013 Jun; 90(6):494-500. PubMed ID: 23470153
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pulsed high-dose dexamethasone modulates Th1-/Th2-chemokine imbalance in immune thrombocytopenia.
    Liu Z; Wang M; Zhou S; Ma J; Shi Y; Peng J; Hou M; Guo C
    J Transl Med; 2016 Oct; 14(1):301. PubMed ID: 27776524
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Polymorphisms of the IL-23R gene are associated with primary immune thrombocytopenia but not with the clinical outcome of pulsed high-dose dexamethasone therapy.
    Zhan Y; Hua F; Ji L; Wang W; Zou S; Wang X; Li F; Cheng Y
    Ann Hematol; 2013 Aug; 92(8):1057-62. PubMed ID: 23564312
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High-dose cycles of dexamethasone in idiopathic thrombocytopenic purpura.
    Calabresi AR; Veith RW; Rigby PG
    J La State Med Soc; 2004; 156(5):269-72. PubMed ID: 15554097
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rituximab chimeric anti-CD20 monoclonal antibody treatment for adult refractory idiopathic thrombocytopenic purpura.
    Braendstrup P; Bjerrum OW; Nielsen OJ; Jensen BA; Clausen NT; Hansen PB; Andersen I; Schmidt K; Andersen TM; Peterslund NA; Birgens HS; Plesner T; Pedersen BB; Hasselbalch HC
    Am J Hematol; 2005 Apr; 78(4):275-80. PubMed ID: 15795920
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Investigation of TNF-alpha, TGF-beta 1, IL-10, IL-6, IFN-gamma, MBL, GPIA, and IL1A gene polymorphisms in patients with idiopathic thrombocytopenic purpura.
    Pehlivan M; Okan V; Sever T; Balci SO; Yilmaz M; Babacan T; Pehlıvan S
    Platelets; 2011; 22(8):588-95. PubMed ID: 21591983
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Response of resistant idiopathic thrombocytopenic purpura to pulsed high-dose dexamethasone therapy.
    Andersen JC
    N Engl J Med; 1994 Jun; 330(22):1560-4. PubMed ID: 8177245
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Initial treatment of immune thrombocytopenic purpura with high-dose dexamethasone.
    Cheng Y; Wong RS; Soo YO; Chui CH; Lau FY; Chan NP; Wong WS; Cheng G
    N Engl J Med; 2003 Aug; 349(9):831-6. PubMed ID: 12944568
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Circulating dendritic cells subsets and CD4+Foxp3+ regulatory T cells in adult patients with chronic ITP before and after treatment with high-dose dexamethasome.
    Ling Y; Cao X; Yu Z; Ruan C
    Eur J Haematol; 2007 Oct; 79(4):310-6. PubMed ID: 17692100
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combination therapy (intratympanic dexamethasone + high-dose prednisone taper) for the treatment of idiopathic sudden sensorineural hearing loss.
    Battaglia A; Burchette R; Cueva R
    Otol Neurotol; 2008 Jun; 29(4):453-60. PubMed ID: 18401285
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Alteration and biological significance of peripheral dendritic cells in patients with chronic idiopathic thrombocytopenic purpura].
    Ling Y; Cao XS; Yu ZQ; Qiu GQ; Ruan CG
    Zhonghua Xue Ye Xue Za Zhi; 2008 Mar; 29(3):187-91. PubMed ID: 18788620
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.